Detalhe da pesquisa
1.
Optimizing the antiretroviral treatment focusing on long-term effectiveness and a person-centered approach. Consensus Guidance Using a Delphi Process.
New Microbiol
; 46(4): 367-380, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38252048
2.
Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With Human Immunodeficiency Virus 1 (HIV-1): Week 48 Results From the Phase 3, Noninferiority SALSA Randomized Trial.
Clin Infect Dis
; 76(4): 720-729, 2023 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35235656
3.
Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96-week, phase 3b, open-label, switch trial in virologically suppressed people ≥65 years of age.
HIV Med
; 24(1): 27-36, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35527425
4.
Pillars of long-term antiretroviral therapy success.
Pharmacol Res
; 196: 106898, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37648103
5.
SARS-CoV-2 infection clinical picture and outcomes in adults living with HIV: a cohort analysis.
New Microbiol
; 46(1): 18-23, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36853813
6.
Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients.
BMC Infect Dis
; 22(1): 782, 2022 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36224538
7.
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting.
J Viral Hepat
; 28(3): 558-568, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33306247
8.
SARS-CoV-2 infection in persons living with HIV: A single center prospective cohort.
J Med Virol
; 93(2): 1145-1149, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32706409
9.
Antibody response to SARS-CoV-2 vaccination is extremely vivacious in subjects with previous SARS-CoV-2 infection.
J Med Virol
; 93(7): 4612-4615, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33788281
10.
In vitro susceptibility to fostemsavir is not affected by long-term exposure to antiviral therapy in MDR HIV-1-infected patients.
J Antimicrob Chemother
; 75(9): 2547-2553, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32464638
11.
Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort.
J Antimicrob Chemother
; 75(3): 681-689, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31865395
12.
Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: a multi-cohort study.
J Antimicrob Chemother
; 75(1): 194-199, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31605107
13.
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure.
J Hepatol
; 71(6): 1106-1115, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31433303
14.
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C.
J Hepatol
; 70(3): 379-387, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30472321
15.
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: a multicenter retrospective cohort study from 2007 to 2015.
BMC Infect Dis
; 18(1): 285, 2018 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29940869
16.
Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients.
BMC Infect Dis
; 17(1): 215, 2017 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28302065
17.
Systemic inflammation-based scores and mortality for all causes in HIV-infected patients: a MASTER cohort study.
BMC Infect Dis
; 17(1): 193, 2017 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28264665
18.
Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort.
BMC Infect Dis
; 17(1): 212, 2017 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28298195
19.
Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials.
Clin Infect Dis
; 63(2): 268-80, 2016 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27090986
20.
Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection.
N Engl J Med
; 369(19): 1807-18, 2013 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24195548